WebThe achievement of CR is the crucial step for a prolonged PFS and OS after an autologous SCT in multiple myeloma (MM). Unfortunately, even with the use of new regimens and the … WebJan 9, 2024 · The increase in the number of therapeutic alternatives for both newly diagnosed and relapsed/refractory multiple myeloma (RRMM) patients has widened the clinical scenario, leading to a level of complexity that no algorithm has been able to cover up to date. At present, this complexity increases due to the wide variety of clinical situations …
Treating Biochemical Relapses in Multiple Myeloma - AJMC
WebTreatment for relapsed myeloma. Relapse is the term healthcare professionals use when someone has responded well to treatment, but the condition has come back after a while. … WebMay 12, 2024 · Continuous lenalidomide-based therapy is used extensively at first-line, and resistance to lenalidomide has become the key factor for the choice of salvage therapy. Daratumumab is increasingly used in first-line, and soon patients that relapse while on daratumumab will become a common challenge. Three-drug regimens are the standard … エクセル 再表示 a列 できない
Treating Biochemical Relapses in Multiple Myeloma - AJMC
WebMultiple myeloma: This classification means tests show multiple groups of abnormal plasma cells, high M protein levels in blood or urine and a high percentage of abnormal … WebJan 20, 2024 · The prognosis of multiple myeloma (MM) has dramatically improved with the development of new drugs, and it has become important to determine the appropriate … WebDec 13, 2024 · Relapsed/refractory multiple myeloma (RRMM) is an aggressive form of myeloma that can be hard to treat and lead to poor outcomes. Most people with myeloma … エクセル 再表示 キーボードショートカット